Ina Lee, M.D., Ph.D.

Assistant Research Physician

Dr. Lee is a molecular pathologist in NCI COMPASS, which provides state-of-the-art clinical sequencing services to CCR principal investigators. Her interests include genomic features of hematologic malignancies, integrated precision diagnostics and monitoring of hematolymphoid neoplasms, and the underlying biology of myeloid neoplasms. 

Areas of Expertise

1) neoplasm molecular genomics, 2) hematolymphoid neoplasia

Contact Info

Ina Lee, M.D., Ph.D.
Center for Cancer Research
National Cancer Institute
Building 10, Room 2S235
Bethesda, MD 20892-1500
Ph: 240-858-7290
ina.lee@nih.gov

Dr. Lee is currently involved in clinical utilitization of developing molecular technologies for precision diagnostics in the setting of malignant and pre-malignant neoplasia. She is specifically interested in the integration of molecular genetics and genomics testing into multidisciplinary diagnostic and monitoring strategies for hematolymphoid neoplasms. 

NIH Scientific Focus Areas:
Cancer Biology, Cell Biology, Clinical Research, Genetics and Genomics

Selected Key Publications

  1. Lee I, Gudipati MA, Waters E, Duong VH, Baer MR, Zou Y.
    Mol Cytogenet. 12: 47, 2019. [ Journal Article ]
  2. Posttransplant Classic Hodgkin Lymphoma: Richter Transformation or Posttransplant Lymphoproliferative Disorder?.
    Lee I, Zou Y, Hodges S, Rapoport AP, Hardy N, Singh Z.
    AJSP: Reviews & Reports. 24: 212-217, 2019. [ Journal Article ]
  3. Lee I, Bos S, Li G, Wang S, Gadea G, Desprès P, Zhao RY.
    Viruses. 10(5): 233, 2018. [ Journal Article ]

Dr. Lee earned her M.D. and Ph.D. through the Medical Scientist Training Program at the University of Illinois at Chicago School of Medicine. She then completed a combined pathology residency (AP/CP) and hematopathology fellowship at the University of Maryland Medical Center in Baltimore, MD, followed by a Molecular Genetic Pathology fellowship at the University of North Carolina, Chapel Hill, NC.